Ryan Jacobs, MD^1*, Ruibin Wang, PhD^2*, Jinghua He, PhD^2*, Xiaoxiao Lu, PhD, MD, MPH^3*, Linda Wu, PhD^3*, Wasiulla Khan, PhD^3*, Zaina P. Qureshi, PhD, MS, MPH^3* and Moshe Yair Levy, MD⁴

¹Hematology, Atrium Health Levine Cancer Institute, Charlotte, NC
²Janssen Scientific Affairs, LLC, Titusville, NJ
³Janssen Scientific Affairs, LLC, Horsham, PA
⁴Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX

Agrima Mian, MBBS, MD¹, Wei Wei, MSc^2*, Rajshekhar Chakraborty, MBBS³, Jean C. Yi, PhD^4*, Jaime M. Preussler, MS⁵, Brian T. Hill, MD, PhD⁶, Jan Cerny, MD, PhD⁷, Abhinav Deol, MD⁸, Theresa E. Hahn, PhD⁹, Shahrukh K. Hashmi, MD, MPH¹⁰, Samantha Jaglowski, MD, MPH¹¹, Heather S. L. Jim, PhD^12*, Nandita Khera, MD, MPH¹³, Alison W. Loren, MD¹⁴, Joseph P. McGuirk, DO¹⁵, Bipin N. Savani, MD¹⁶, Patrick Stiff, MD¹⁷, Joseph P. Uberti, M.D., Ph.D.¹⁸, Victoria Whalen, B.S.^19*, John R. Wingard, MD²⁰, Jana Reynolds, MD²¹, Shernan G Holtan, MD²², William A. Wood, MD, MPH²³, K. Scott Baker, MD, MS²⁴, Karen L. Syrjala, PhD^25*, Betty K. Hamilton, MD⁶ and Navneet S. Majhail, MD²⁶

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
³Hematology and Oncology, Columbia University Medical Center, New York, NY
⁴Biobehavioral Sciences Department, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵National Marrow Donor Program/Be The Match, Minneapolis, MN
⁶Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁷University of Massachusetts Medical School, Worcester, MA
⁸Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI
⁹Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN
¹¹Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH
¹²Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL
¹³Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
¹⁴Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁶Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
¹⁷Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL
¹⁸Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
¹⁹Section of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE
²⁰Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL
²¹Baylor University Medical Center, Dallas, TX
²²University of Minnesota, Minneapolis, MN
²³Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
²⁴Fred Hutchinson Cancer Research Ctr., Seattle, WA
²⁵Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²⁶Sarah Cannon, Nashville, TN

Tycel Phillips, MD^1*, Pieternella Lugtenburg, MD, PhD², Anupama Kalsekar, MS^3*, Alex Mutebi, PhD^3*, Anthony Wang, PhD, MPH^4*, Julie Blaedel, MD^3*, Katherine Kosa, MPH^5*, Susan Martin, MPH^5*, Mariana Sacchi, MD^3* and Catherine Thieblemont, MD, PhD⁶

¹University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
²Department of Hematology, On behalf of the HOVON lymphoma working group, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
³Genmab, Princeton, NJ
⁴AbbVie, Inc., North Chicago, IL
⁵RTI Health Solutions, Ann Arbor, MI
⁶APHP, Hôpital Saint-Louis, Hemato-Oncology, Paris, France; Diderot University, Sorbonne Paris-Cité, Paris, France

Carolyn Owen, MD¹, Neil Chua, MD^2*, Devon Boyne^3,4*, Ofodile Joe-Uzuegbu^4,5*, Huma Shakir^3,4*, Priyanka Gonga^3,4*, Darren Brenner^3,4,6*, Julia Elia-Pacitti^7*, Emmanuel Ewara^7* and Winson Y Cheung, MD MPH^3,4*

¹Departments of Medicine and Oncology, University of Calgary, Calgary, AB, Canada
²Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
³Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada
⁴Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
⁵Oncology Outcomes Research Initiative,, University of Calgary, Calgary, AB, Canada
⁶Department of Community Health Science, University of Calgary, Calgary, AB, Canada
⁷Janssen Inc., Toronto, ON, Canada

Kara I. Cicero, MD, MPH¹, Alfred I. Neugut, MD, PhD^2*, Andrew H. Doyle^3*, Divaya Bhutani, MD⁴, Amer Assal, MD⁵, Ran Reshef, MD, MSc⁶, Markus Y. Mapara, MD⁷, Suzanne Lentzsch, MD, PhD⁸ and Rajshekhar Chakraborty, MBBS⁹

¹New York Presbyterian, Columbia University Medical Center, New York, NY
²Columbia University Medical Center, New York
³Columbia University, New York, NY
⁴Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
⁵Blood and Marrow Transplantation Program, Columbia University Medical Center, New York, NY
⁶Blood and Marrow Transplantation Program, Columbia University, New York, NY
⁷Department of Medicine, Division of Hematology/Oncology, Columbia University College of Physcians and Surgeons, New York, NY
⁸Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY
⁹Hematology and Oncology, Columbia University Medical Center, New York, NY

Anca Prica, MD, MSc¹, Tiana Coley, BS^1*, Rachel Aitken, MSc^1*, Abi Vijenthira, MD¹, Manjula Maganti, MSc^2*, Samantha J Mayo, PhD, RN^3*, Christine I. Chen, MD¹, John Kuruvilla, MD¹, Michael Crump, MD¹, Sita Bhella, M.D., MSc^1*, Robert Kridel, MD¹, Vishal Kukreti, MD, FRCP, MSc¹, Chloe Yang, MD^1* and Shabbir Alibhai, MD, MSc, FRCP^4*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
²Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
³Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
⁴Department of Medicine, University Health Network, Toronto, ON, Canada

Blake Foxworthy, MD^1*, Elizabeth C Davis, MSPH^2*, Ana C. Xavier, MD¹, Julienne Brackett, MD, MS³, David Dickens, MD^4*, Alissa R. Kahn, MD^5*, Isaac Martinez^6*, Archana Sharma, DO^7*, Carla Schwalm, MD^8*, Jessica M. Foley, MD⁹, Jennifer J. Wilkes, MD, MSCE¹⁰, Smita Bhatia, MD, MPH⁶, Jennifer M Levine, MD, MS^11*, Emily Johnston, MD, MS⁶ and Julie A. Wolfson, MD, MS¹²

¹University of Alabama at Birmingham, Birmingham, AL
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL
³TX Children's Children Cancer & Hematology Centers, Houston, TX
⁴Division of Pediatric Hematology and Oncology, University of Iowa, Iowa City, IA
⁵St. Joseph's Health, Paterson, NJ
⁶Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁷Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
⁸Bronson Health Group, Kalamazoo, MI
⁹Helen Devos Children's Hospital, Grand Rapids, MI
¹⁰Seattle Children's Hospital, Seattle, WA
¹¹Weill Cornell Medical College, New York, NY
¹²Pediatric Hematology-Oncology, Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL

Camila Alves da Silva, MD^1*, Juliana Pereira, MD, PhD², Eduardo M Rego, MD, PhD^3,4, Vanderson Rocha, MD, PhD^4* and Wellington F Silva Jr., MD PhD⁴

¹Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
²Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SAO PAULO, Brazil
³Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology, Department of Hematology (LIM-31), University of Sao Paulo, São Paulo, Brazil
⁴Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil

Max J. Gordon, MD¹, Zhigang Duan, MS^2*, Hui Zhao^3*, Loretta J. Nastoupil, MD⁴, Alessandra Ferrajoli⁵, Alexey V Danilov, MD⁶ and Sharon Giordano, MD^7*

¹University of Texas MD Anderson, Houston
²University of Texas MD Anderson, Texas, TX
³University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶City of Hope, La Canada Flintridge, CA
⁷University of Texas MD Anderson, Houston, TX

Amaris K. Balitsky, MD, MSc, FRCPC^1,2, Gregory R Pond, PhD, PStat^2*, Graeme Fraser, MD, MSc, FRCPC^1,2, Tom Kouroukis, MD, MSc , FRCPC^1,2 and Stephen Ronan Foley, MD, FRCPC^1,2

¹Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada
²Department of Oncology, McMaster University, Hamilton, ON, Canada

Samer Al Hadidi, MD, MSc¹, Aniko Szabo, PhD^2*, Jean Esselmann^3*, Lindsay Hammons, MD⁴, Munawwar Hussain, MD^5*, Yetunde Ogunsesan, MD^5*, Nishanth Thalambedu, MD^6*, Fatima Khan^6*, Jaskirat Sethi, MD^5*, Abhishek Janardan^3*, Sabarinath Radhakrishnan^7*, Sharmilan Thanendrarajan, MD¹, Carolina Schinke¹, Binod Dhakal, MBBS⁸, Siegfried Janz⁹, Saurabh Chhabra, MD, MS¹⁰, Anita D'Souza, MD, MS¹¹, Maurizio Zangari, MD¹, Frits van Rhee⁵ and Meera Mohan, MD¹²

¹Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
²Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
³Bone Marrow Transplant Service, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI
⁴Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
⁵Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
⁶Myeloma Center, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
⁷Medical college of Wisconsin, Milwaukee, WI
⁸Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁹Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁰Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹¹Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
¹²Medical College of Wisconsin, Milwaukee, WI

Sikander Ailawadhi¹, Arliene Ravelo, MPH^2*, Carmen Ng, PhD^2*, Bonny Shah, MPH^3*, Rongrong Wang, MPH^2*, Katherine Eakle, PharmD^2* and Juliana Biondo, MD²

¹Mayo Clinic, Jacksonville, FL
²Genentech, Inc., South San Francisco, CA
³Genesis Research, Hoboken, NJ

Chattip Prueksapraopong, MD^1,2, Trevor Hirata^3*, Lauryn Liao^3*, Kyle Ishikawa^4*, John J. Chen^4*, Wade Kyono, MD^4,5*, Darryl W. Glaser, MD^4,5*, Randal Wada, MD^4,5*, Rodolfo Bégué, MD^4,6*, Brian T. Fisher, DO, MSCE^7*, Lena E. Winestone, MD⁸, Kelley C. Okimoto, MD^4,5* and Stephanie Si Lim, MD^3,4,5

¹Pediatric Residency Program, University of Hawai’i, John A. Burns School of Medicine, Honolulu, HI
²Kapi’olani Medical Center for Women and Children, Honolulu, HI
³University of Hawai’i Cancer Center, Honolulu, HI
⁴University of Hawai’i, John A. Burns School of Medicine, Honolulu, HI
⁵Division of Hematology Oncology, Kapi’olani Medical Center for Women and Children, Honolulu, HI
⁶Division of Infectious Diseases, Kapi’olani Medical Center for Women and Children, Honolulu, HI
⁷Division of Infectious Disease, Children's Hospital of Philadelphia, Philadelphia, PA
⁸Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA

Sophia C Cornew, MBA^1*, Anthony B Cardillo^2*, Louis J DeGennaro, PhD³, Paul A Fields, PhD^4*, Lore M Gruenbaum, PhD³, Hana Littleford, PhD^2*, Richard L Martin, PhD^2*, Gwen L Nichols, MD³, Amanda C Nottke, PhD^2*, Conner M O'Brien, BS^2*, Sneha T Reddy, MD^3*, Rhonda Rosenbaum, MS^2*, Larry A Saltzman, MD^3*, Catherine Sanders, PhD^4*, Jun Xu, PhD³ and Lee M Greenberger, PhD³

¹1400 16th Street, Invitae, San Francisco, CA
²Invitae, San Francisco, CA
³The Leukemia & Lymphoma Society, Rye Brook, NY
⁴Adaptive Biotechnologies, Seattle, WA

Alexander Didier^1*, Ying Ning, MD^1*, Andrew Campbell, MD^1* and Danae M Hamouda, MD²

¹Department of Medicine, The University of Toledo College of Medicine and Life Sciences, Toledo, OH
²University of Toledo/University of Toledo Medical Center & Dana Cancer Center, toledo, OH

Gayathri Ravi, MD¹, Smith Giri, MD, MHS², Susan Bal, MD³, Kelly N. Godby, MD^4*, Vishnu V.B. Reddy, MD⁵, Donna Salzman, MD⁶, Omar Alkharabsheh, MBBS⁷, Scott A. McDaniel, MD^8*, Melissa Sentell^9* and Luciano J. Megala Costa, MD, PhD¹⁰

¹Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
³O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
⁴Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Hospital, Birmingham, AL
⁵Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
⁶University of Alabama at Birmingham, Birmingham, AL
⁷Mitchell Cancer Institute, University of South Alabama, Mobile, AL
⁸Alabama Oncology Hematology Associates, Montgomery, AL
⁹University of Alabama, Birmingham, AL
¹⁰University of Alabama at Birmingham Hospital, Vestavia, AL

Ana Vagos Mata, M.D.^1,2*, Daniel Gomes, M.D.^3*, Pedro Mendonça, Medical Student^4*, Pedro De Vasconcelos, M.D.^5*, Daniela Alves, MD^6,7*, João Santos Silva, M.D.^3*, João Ribeiro, M.D.^3*, João F Lacerda, M.D., PhD^8,9 and João Raposo, M.D.^8*

¹Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal, Lisbon, Portugal
²Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, Lisboa, Portugal
³Serviço de Medicina Intensiva, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, Lisbon, Portugal
⁴Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, Lisbon, Portugal
⁵Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, Lisbon, Portugal
⁶Department of Hematology and Marrow Transplantation, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, Portugal
⁷Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
⁸Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
⁹Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Jenna L Tate, MSc^1*, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD², Kathryn Riley^3*, Lydia Skertchly^4*, Thea Chandler, MD^4*, Frances Seymour^5* and Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath^6*

¹Haematology, St James's University Hospital, Leeds, United Kingdom
²Leeds Teaching Hospitals NHS Trust, Leeds, ENG, United Kingdom
³Department of Haematology, St James University Hospital, Leeds, United Kingdom
⁴St James's University Hospital, Leeds, United Kingdom
⁵Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁶Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Allison Winter, MD¹, Nicholas Liu, PharmD^2*, Andy Surinach, MPH^3*, Michelle A. Fanale, MD², Kristina S. Yu, PhD, MPH, RPh^2* and Mayur Narkhede, MBBS⁴

¹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Seagen Inc., Bothell, WA
³Genesis Research, Hoboken, NJ
⁴University of Alabama-Birmingham, Birmingham, AL

Tariqa Ackbarali, PhD^1*, Susan M. O'Brien², Anthony R. Mato, MD, MSCE³ and Matthew S. Davids, MD⁴

¹PlatformQ Health, Lake Worth, FL
²UCI Cancer Center, Orange, CA
³CLL Program, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
⁴Department of Medical Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA

Mehdi Hamadani, MD¹, Laura Liao^2*, Lauren Wilson, MPH^3*, Amanda Howarth, MPH^3*, Carlos Flores, MPH^3* and Lei Chen, MD, PhD^2*

¹Department of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
²ADC Therapeutics America, Inc., New Providence, NJ
³Genesis Research, Hoboken, NJ

Akiva Diamond, MD¹, Wyatt P. Bensken, PhD^2*, Long Vu, MS^2*, Siran M. Koroukian, PhD^2* and Paolo F. Caimi, MD^3,4

¹Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke's Medical Center, Houston, TX
²Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH
³Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
⁴Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Neda Alrawashdh, PharmD^1* and Ivo Abraham, PhD, RN²

¹Center for Health Outcomes and Pharmacoeconomic Research, university of arizona, TUCSON, AZ
²Center for Health Outcomes and PharmacoEconomic Research, University of Arizona - College of Pharmacy, Tucson, AZ

Catherine Thieblemont, MD, PhD¹, Qiufei Ma^2*, Christian Hampp^2*, James Harnett^2*, Rachel E. Sobel^2*, Jessica J. Jalbert, PhD^2*, Ruben G.W. Quek^2*, Wenhui Wei, PhD^2*, Ning Wu^2*, Vera Mastey^2*, Joy Wang^2*, Anit Bajwa^2*, Benedikt Maissenhaelter^3*, Chantal van Gils^4*, Shivani Aggarwal^5*, Aafia Chaudhry, MD, MBA, MS^2*, Hesham Mohamed, MD^2*, Srikanth R. Ambati, MBBS, MD^2*, Emmanuel Bachy, MD, PhD^6* and Gandhi Laurent Damaj, MD, PhD^7*

¹Université de Paris, Assistance Publique – Hôpitaux de Paris, Hopital Saint-Louis, Hemato-Oncologie, Paris, France
²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
³IQVIA, Munich, Germany
⁴IQVIA, Rotterdam, Netherlands
⁵IQVIA, Los Angeles, CA
⁶Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
⁷Institut d'Hematologie de Basse-Normandie, CHU Cote de Nacre, Université de Normandie, Caen, France

Avi Leader, MD^1,2*, Hila Magen, MD^1,3*, Irina Amitai, MD^4,5*, Antoine Pironet, PhD^6*, Eric Tousset, M.Sc.^6*, Alon Rozental, MD^1,7*, Sabina De Geest, PhD RN^8,9*, Iuliana Vaxman, MD, BA^1,2*, Pia Raanani, MD^1,7 and Arnon Nagler, MD^1,10

¹Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
³Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel
⁴Division of Hematology, Chaim Sheba Medical Center, Ramat-Gan, Israel
⁵Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
⁶AARDEX Group, Liège, Belgium
⁷Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
⁸Institute of Nursing Science, Department Public Health, University of Basel, Basel, BS, CHE
⁹Academic Centre of Nursing and Midwifery, Department Public Health and Primary Care, KU Leuven, Leuven, Belgium
¹⁰Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel

Fieke W Hoff, MD, PhD¹, Yazan F. Madanat, MD², Heather Lapidus Glassner^3* and Beth Schneider^3*

¹UT Southwestern Medical Center, Dallas, TX
²Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
³My Health Team, San Francisco

Sujitha Ketineni, MD¹, Calvin Abro, MD¹, Xianming Zhu, MBBS, MPH^2*, Vivek Prakash, MS, MBA^3*, Sarah S. Makhani, MD⁴, Kathy Robinson, PhD^1*, Aliyah Hashmi, BS^5*, Bhavya Vemuri, MD^6*, Mohammad Hussain, MD^1* and Ruchika Goel, MD, MPH^1,7

¹Division of Hematology/Oncology, Simmons Cancer Institute, SIU School of Medicine, Springfield, IL
²Johns Hopkins Medicine, Baltimore, MD
³Center for Clinical Research, SIU School of Medicine, Springfield, IL
⁴Department of Medicine, NYU Langone Health, New York City, NY
⁵SIU School of Medicine, Springfield, IL
⁶St. Mary's Hospital, Waterbury, CT
⁷Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD

Polina Bellman, MD¹, Wei Cui, MD^2,3*, Zahra Mahmoudjafari, PhD^2,4*, Shebli Atrash, MD^2,5, Barry Paul, MD, MS^2,6, Hamza Hashmi, MD^2,7, Rajesh Banderudrappagari^8*, Leyla O. Shune, MD^9,10, Al-Ola Abdallah, MD^10,11 and Nausheen Ahmed, MD^2,12

¹University of Kansas Medical Center, Kansas city, KS
²US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, KS
³University of Kansas Medical Center, Kansas City, KS
⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁵Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁶Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC
⁷Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
⁸CoxHealth, Springfield, MO
⁹The University of Kansas Medical Center, Kansas City, KS
¹⁰US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS
¹¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹²Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS

Calvin Abro, MD¹, Sujitha Ketineni, MD¹, Sarah S. Makhani, MD², Xianming Zhu, MBBS, MPH^3*, Bhavya Vemuri, MD^4*, Vivek Prakash, MS, MBA^5*, Kathy Robinson, PhD^1*, Mohammad Hussain, MD^1* and Ruchika Goel, MD, MPH^1,6

¹Division of Hematology/Oncology, Simmons Cancer Institute, SIU School of Medicine, Springfield, IL
²Department of Medicine, NYU Langone Health, New York City, NY
³Johns Hopkins Medicine, Baltimore, MD
⁴St. Mary's Hospital, Waterbury, CT
⁵Center for Clinical Research, SIU School of Medicine, Springfield, IL
⁶Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD

Megan C Braunlin, MPH^1*, Tingting Gong, MS^2*, Rebecca Payne^3*, Chuanyu Kou, MS^2*, Babatunde Adedokun, MD, PhD^1*, Kelly Velasco, PharmD^4* and Shuling Li, PhD²

¹Center for Observational Research, Amgen Inc., Thousand Oaks, CA
²Chronic Disease Research Group, Minneapolis, MN
³SimulStat, Solana Beach, CA
⁴Medical Affairs, Amgen Inc., Thousand Oaks, CA

Alexander Russell-Smith, MSc^1*, Louise Murphy, PhD^2*, Amy Nguyen, PhD^2*, Feng Cao, PhD, MS^2*, Shiqiang Li, MS^2* and Richa Shah, PharmD³

¹Pfizer R&D Ltd, Sandwich, NY, United Kingdom
²Optum, Eden Prairie, MN
³Pfizer Inc., New York

Rashmi Suresh Yawalkar, MBBS, MD^1*, Mobin Paul, MBBS, MD, DM^2*, Reshmy G S, M.Sc Medical biochemistry^3*, Mrudula E.V., M.Sc Medical biochemistry^4*, Rema Ganapathy, MBBS DNB^5*, Manoj Unni, MD DM^6*, Chitresh Yadav, MBBS, MD^7*, Shreya Gopal Agrawal, MBBS, MD^8*, Sandeep abhijit Pattanik, MBBS, MD^9*, Gohul Gopi Jalajakumari,, MBBS, MD^9*, Aswathy Ashok Beenakumary, Clinical pharmacist^9*, Anjaly s Nair, MSc Biostatistics^10*, Ullas Mony, PhD^11* and Neeraj Sidharthan, MD, MBBS, DM, DNB¹²

¹Clinical haematology, AIMS hospital, kochi, India
²Clinical Haematology and Haemato-oncology, Rajagiri Hospital, Aluva, India
³Biochemistry, Amrita institute of Medical sciences, Kochi, India
⁴Biochemistry, Amrita institute of medical sciences, Kochi, AL, IND
⁵Department of Clinical Haematology, Amrita Institute of Medical Sciences, Kochi, India
⁶Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences, Kochi, India
⁷Clinical haematology, Amrita institute of Medical sciences, kochi, India
⁸Clinical Haematology, Amrita institute of Medical sciences, Kochi, India
⁹Clinical haematology, Amrita institute of Medical sciences, Kochi, India
¹⁰Department of Biostatistics, Amrita institute of Medical sciences, Kochi, India
¹¹Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College and Hospitals, Saveetha institute of medical and technical sciences, Chennai, Chennai, India
¹²Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences , Amrita University, Kochi, Kerala, India

Oreofe O. Odejide, MD, MPH¹, Tamryn F. Gray, RN, PhD, MPH^1*, Tsotso Ablorh, MA^2*, Miryam Yusufov, PhD^1*, Gregory A. Abel, MD, MPH¹ and Lizabeth Roemer, PhD^2*

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Psychology, University of Massachusetts, Boston, MA

John L Vaughn, MD, MS¹ and Narendranath Epperla, MD, MS²

¹Yale New Haven Health, New Haven, CT
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Joshua Richter, MD¹, Sikander Ailawadhi², Hans C. Lee, MD³, James W. Hardin, PhD^4*, Howard R. Terebelo, DO⁵, Rafat Abonour, MD⁶, Lynne I. Wagner, PhD^7*, Brian G.M. Durie, MD⁸, James L. Omel, MD^9*, Mohit Narang, MD^10*, Kathleen Toomey, MD^11*, Robert M. Rifkin, MD¹², Cristina J. Gasparetto, MD¹³, Edward Yu, ScD^14*, Jasmeet Anand, PharmD^14*, Liang Liu, MS^14*, Ying-Ming Jou, PhD^14* and Sundar Jagannath¹

¹Mount Sinai Hospital, New York City, NY
²Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
³The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴University of South Carolina, Columbia, SC
⁵Providence Cancer Institute, Southfield, MI
⁶Indiana University, Indianapolis, IN
⁷Wake Forest School of Medicine, Winston Salem, NC
⁸Cedars-Sinai Medical Center, Los Angeles, CA
⁹Myeloma Research Advocate/Advisor, Grand Island, NE
¹⁰US Oncology Research, Columbia, MD
¹¹Steeplechase Cancer Center, Somerville, NJ
¹²Rocky Mountain Cancer Center, Denver, CO
¹³Duke University Medical Center, Durham, NC
¹⁴Bristol Myers Squibb, Princeton, NJ

Mohammad S Ebraheem, MD¹, Eli Muchtar, MD^1*, Shaji K Kumar, MD¹, Angela Dispenzieri, MD¹, Francis K. Buadi, MB¹, David Dingli, MD, PhD¹, Joselle Cook, MBBS¹, Martha Q. Lacy, MD¹, Suzanne R. Hayman, MD¹, Prashant Kapoor, MD¹, Nelson Leung, MD¹, Rahma M Warsame, MD¹, Taxiarchis Kourelis, MD¹, Moritz Binder, MD, MPH¹, Ronald Go, MD¹, Amie Fonder, PA-C^1*, Yi L. Hwa, NP¹, Miriam A. Hobbs, APRN, CNP, DNP^1*, Wilson I. Gonsalves, MD¹, S. Vincent Rajkumar, MD¹, Robert A. Kyle, MD² and Morie A Gertz, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN

Alberto Lázaro García, MD¹, Marta González Rodríguez, MD^2*, Edwin Uriel Suárez Merchán, MD^1*, Gonzalo Castellanos Arias, MD^1*, Alicia de las Heras Moreno, MD^1*, María Pilar Llamas Sillero, MD, PhD^1*, Eduardo García Romo, MD, PhD^3*, Antonio Noguera Tejedor, MD, PhD^3*, Laura Solán Blanco, MD, PhD^1*, Antonio Herrero^4* and Juan Manuel Alonso Dominguez, MD, PhD^1*

¹Department of Hematology, Fundación Jiménez Díaz University Hospital, Madrid, Spain
²Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain
³Department of Palliative Care, Fundación Jiménez Díaz University Hospital, Madrid, Spain
⁴Information and Communication Technology (ICT) Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain

Nick York^1*, Deborah Baker^1*, Kathryn Huntley^1*, Michael Rynne^1*, Nicole Schroeter^1*, Jennie Bradley^2*, Anna Schuh, MD, PhD, FRCP, FRCPath³, Nicole Lamanna, MD⁴ and Alina S. Gerrie, MD, MPH, FRCPC⁵

¹CLL Advocates Network, Bern, Switzerland
²IQVIA, Chesterfield, ENG, United Kingdom
³Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁴Columbia University, Herbert Irving Comprehensive Cancer Center, New York
⁵BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada

Nishanth Thalambedu, MD^1*, Kuldeepsinh Atodaria, MBBS² and Christian Joseph Fidler, MD^3*

¹Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
²Jefferson Health - Abington, Willow Grove, PA
³Hematology and Medical Oncology, Jefferson Health - Abington, Abington, PA

Kevin Tang, MD^1,2, Heidi M Krause, BS^2*, Nikhil Patel, MD^2*, Grace Hwang, PharmD^3*, Jason Lu, MD^2*, Martha P. Mims, MD, PhD^4,5,6, Mark M. Udden, MD^4,5,6, Courtney Nicole Miller-Chism, MD^4,5,6, Gustavo Rivero, MD^4,5,6 and Purnima Sravanti Teegavarapu, MD^4,5,6

¹Center for Translational Research on Inflammatory Disease (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX
²Department of Medicine, Baylor College of Medicine, Houston, TX
³Department of Pharmacy, Baylor St.Luke's Medical Center, Houston, TX
⁴Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX
⁵Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX
⁶Department of Hematology/Oncology, Baylor St Luke's Medical Center, Houston, TX

Oluwasegun Akinyemi, MD^1,2*, Faith O Abodunrin, MD³, Oluwatayo Adeoye, MD^4*, Akinwale Akingbule, MD, MS^5*, Olanrewaju Oni, MD, MS^6*, Bolarinwa Akinwumi, MD, MS^7*, Ademola Ojo, MD^8*, Oluwaseun B Ogunbona, MBBS PhD^9* and Peter Silberstein, MD^10*

¹The Clive O. Callender Outcomes Research Center, Howard University College of Medicine, Macomb, IL
²Department of Health Policy and Management, University of Maryland School of Public Health, College Park, MD
³Department of Internal Medicine, Creighton University, OMAHA, NE
⁴Department of Internal Medicine, St Elizabeth's Medical Center, Boston, MA
⁵Department of Public Health, Ozark valley medical Clinic,, Branson, MO
⁶Department of Pathology, Howard University College of Medicine, Washington, DC
⁷Western Illinois University, Macomb, IL
⁸Department of Internal Medicine, Howard University College of Medicine, Washington, DC
⁹Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX
¹⁰Department of Medicine, Creighton University Medical Center, Omaha, NE

Isabel González-gascón-y-Marín, MD, PhD^1*, Sara Martínez-Flores, MD^2*, Elena Landete, MD^1*, Elena Baeza-Monedero, MD^2*, María Ángeles Foncillas, MD^1*, Paula Fernández-Montalbán, MD^2*, Carolina Cecilia Muñoz-Novas, MD^1*, Maria Stefania Infante, MD^1*, Karen Marín-Mori, MD^1*, Juan Churruca Sarasqueta, MD^1*, Laura Sánchez-Paz, MD^1*, Victoria Ramos-de-Ascanio, MD^1*, Fátima Brañas, MD, PhD^2* and José Ángel Hernández-Rivas, MD, PhD^1,3*

¹Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
²Geriatrics Department, Hospital Universitario Infanta Leonor, Madrid, Spain
³Medicine Department, Universidad Complutense de Madrid, Madrid, Spain